Rapid treatment of acute HCV infection prevents progressionBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7317.826/a (Published 13 October 2001) Cite this as: BMJ 2001;323:826
- Deborah Josefson
- San Francisco
Rapid treatment of acute hepatitis C virus (HCV) infection with interferon may prevent progression to chronic infection, a new study has said.
The results of a pilot study were so impressive that the paper describing them has been released early by the New England Journal of Medicine. The article, scheduled for paper publication on 15 November, is accessible at www.nejm.org.
The research was financed by the pharmaceutical company that manufactures interferon, Essex-Pharma of Munich, Germany.
Drs Elmar Jaeckel, Michael Manns, and colleagues from the Medizinische Hochschule of Hannover, Germany, in association with Teresa Santantonio and Giuseppe Pastore from the infective diseases division of the University of Bari, Italy, enrolled 44 patients with early hepatitis C …
Log in using your username and password
Log in through your institution
Sign up for a free trial